Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Immune-mediated and lipid-mediated platelet function in atherosclerosis
M Ahmadsei, D Lievens, C Weber… - Current opinion in …, 2015 - journals.lww.com
A better understanding of the molecular mechanisms of platelet-related immune activity
allows their utilization as powerful diagnostic tools or targets of therapeutic intervention …
allows their utilization as powerful diagnostic tools or targets of therapeutic intervention …
Practical experience with ticagrelor: an Australian and New Zealand perspective
SA Harding, WJ Van Gaal, R Schrale… - Current Medical …, 2015 - Taylor & Francis
Objective: Ticagrelor is recommended in local and international guidelines as first-line
therapy in combination with aspirin in patients presenting with acute coronary syndromes …
therapy in combination with aspirin in patients presenting with acute coronary syndromes …
[PDF][PDF] Antiplatelet therapy before cardiac surgery
S Demertzis, C Tiziano, C Gabriele - Cardiovascular Medicine, 2016 - zora.uzh.ch
Patients under double antiplatelet therapy (DAPT) waiting for cardiac surgery need careful
multidisci plinary evaluation by the heart team. The decisions on if and when to stop oral …
multidisci plinary evaluation by the heart team. The decisions on if and when to stop oral …
Anticoagulation and Antiplatelet Agents in Peripheral Arterial Interventions
J Taylor, HR Stiepel III, N Keefe - Seminars in Interventional …, 2022 - thieme-connect.com
Effective revascularization of peripheral artery disease relies on periprocedural
pharmacological regulation of the clotting cascade. Patient-specific factors such as …
pharmacological regulation of the clotting cascade. Patient-specific factors such as …
Efektivitas Dan Keamanan Antikoagulan Pada Sindroma Koroner Akut Tanpa Elevasi Segmen St
DC Hapsari, S Suwaldi… - Jurnal Manajemen Dan …, 2014 - journal.ugm.ac.id
Sindroma koroner akut (SKA) disebabkan oleh ketidakseimbangan antara pasokan oksigen
dengan kebutuhan oksigen di miokardium. Terapi antikoagulan pada SKA dapat …
dengan kebutuhan oksigen di miokardium. Terapi antikoagulan pada SKA dapat …
Pituitary Apoplexy Induced by Anticoagulant Therapy in Patient with AcuteCoronary Syndrome
M Johan, H Pangestu - Indian Journal of Case Reports, 2024 - mansapublishers.com
Pituitary apoplexy, defined as bleeding or infarcton the pituitary gland often occurs in
undiagnosed pituitary tu mors. The patientpresented to the emergency room with complaints …
undiagnosed pituitary tu mors. The patientpresented to the emergency room with complaints …
Hubungan antara Anemia dean Lama Rawat Inap pada Pasien dengan Infark Miokard Akut
GC Hartanto - 2020 - digilib.uns.ac.id
Metode: Penelitian analitik observasional ini menggunakan pendekatan potong lintang.
Subjek penelitian diambil menggunakan metode purposive sampling sebanyak 68 pasien …
Subjek penelitian diambil menggunakan metode purposive sampling sebanyak 68 pasien …
Evaluation of platelet activity by multiple electrode impedance aggregometry in acute coronary syndromes: pilot study in a Brazilian tertiary-care public hospital
A De Lorenzo, M Dutra, MA Mattos, HCV Rey… - Brazilian Journal of …, 2019 - SciELO Brasil
There is no definite recommendation for testing platelet aggregation (PA) in acute coronary
syndromes (ACS) due to inconclusive evidence on the usefulness of platelet function tests to …
syndromes (ACS) due to inconclusive evidence on the usefulness of platelet function tests to …
[PDF][PDF] Antitrombotična terapija bolesnika sa akutnim gastrointestinalnim krvarenjem
RJ Tomašević, E Dimitrijević, S Apostolović… - researchgate.net
Savremena terapija akutnog koronarnog sindroma (AKS) podrazumeva agresivnu upotrebu
antitrombotične terapije, što danas podrazumeva rutinsko uključivanje dvojne …
antitrombotične terapije, što danas podrazumeva rutinsko uključivanje dvojne …
Avaliação do bloqueio da atividade plaquetária na síndrome coronariana aguda
MF Dutra - 2017 - dspace.inc.saude.gov.br
Introdução: O bloqueio medicamentoso da atividade plaquetária (BAP) é utilizado como
tratamento padrão das síndromes coronarianas agudas (SCA), porém não é avaliado …
tratamento padrão das síndromes coronarianas agudas (SCA), porém não é avaliado …